Hoot Host is “The Wiser Way” to Grow Online 
Deveron Completes Transaction to Sell Its Assets 
Fonar Announces Financial Results for The 2nd Quarter of Fiscal 2026 Theratechnologies Trogarzo® Data at AIDS 2022 Shows Potential for Improved Treatment Regimens
New sub-analysis on Trogarzo clinical trial patients demonstrates that long-term viral suppression is not influenced…
Petros Pharmaceuticals Responds to Fraudulent Press Release
NEW YORK, July 28, 2022 (GLOBE NEWSWIRE) — Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider…
AIM ImmunoTech Reports Positive Pilot Study Data from Expanded Access Program Evaluating Ampligen® for the Treatment of Long COVID
Growing body of data supports Investigational New Drug (“IND”) application with the U.S. Food and…
Clarus Therapeutics Announces Notice of Allowance for Additional Patent Claims Covering JATENZO® (testosterone undecanoate)
JATENZO is the first and only FDA-approved oral softgel for testosterone replacement therapy in adult…
Avid | Edit On Demand Brings Over-The-Shoulder Collaboration to Remote Production Workflows
SRT support ensures high-quality, secure streams directly from Media Composer for accelerated content review and…
Mirantis Launches Lens Pro – Adding Advanced Features to Accelerate Developers’ Kubernetes Productivity
Adds on-demand live support, easy setup for container image scanning and vulnerability reporting, a built-in…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of F45 Training Holdings Inc. (FXLV) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
GRC Announces Participants for the Second Annual Data Center Liquid Immersion Cooling Awareness Month
GRC will collaborate with Dell Technologies, Intel, and other data center and infrastructure experts to…
Kensu.io appoints Eleanor Treharne-Jones as new Chief Executive Officer
Announces Seed Funding of $4.2M to accelerate Kensu’s growth, open US Headquarters and continue to…
The Magecart Menace Is Now Invisible
ECommerce platforms are fantastic for their adaptability and personalization. From a retail brand’s first forays…
CURE Pharmaceutical Announces the Sale of a Portion of its Platform Technology IP for $20 Million
Proceeds Will Be Used to Grow CURE’s Wellness and Beauty Brands and Its Remaining Proprietary…
Altamira Therapeutics’ Delivery Platform with siRNA Shown to be Effective Treatment for Osteoarthritis as Published in Peer-Reviewed Journal
•Independent peer-reviewed study confirms high potential for OligoPhoreTM delivery platform in RNA-based treatments for osteoarthritis…
Acer Therapeutics and Relief Therapeutics Announce ACER-001 IND Submission for the Treatment of Maple Syrup Urine Disease
Phase 2a trial initiation planned for the first half of 2023 subject to IND clearance…
Veru to Report Fiscal 2022 Third Quarter Financial Results, Host Conference Call on August 11th
MIAMI, July 28, 2022 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused…
Wave Life Sciences to Webcast Conference Call of Second Quarter 2022 Financial Results on August 11, 2022
CAMBRIDGE, Mass., July 28, 2022 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a…
Acer Therapeutics and Relief Therapeutics Announce FDA Acceptance for Review of NDA Resubmission for ACER-001 for Treatment of UCDs
Prescription Drug User Fee Act (PDUFA) target action date set for January 15, 2023 NEWTON,…
Quoin Pharmaceuticals Announces Receipt of Constructive Scientific Advice from EMA for QRX003 Development in Europe
EMA Guidance Provides Clear Path Forward for Quoin’s Netherton Syndrome Product in Europe ASHBURN, Va.,…
Press Release: Online availability of Sanofi’s half-year financial report for 2022
Online availability of Sanofi’s half-year financial report for 2022 Paris, July 28, 2022….
Sunshine Biopharma Increases Support for Anti-Coronavirus Collaborative Research With the University of Arizona
MONTREAL, July 28, 2022 (GLOBE NEWSWIRE) — Sunshine Biopharma Inc. (NASDAQ: “SBFM” and SBFMW) (the…
Agile Therapeutics to Report Second Quarter 2022 Financial Results and Provide Business Update on Thursday, August 11, 2022
Live Conference Call and Webcast at 4:30 p.m. ET PRINCETON, N.J., July 28, 2022 (GLOBE…